Abstract
Aminoglycoside-modifying enzymes were identified in clinical strains ofAcinetobacter calcoaceticus subsp.anitratus (Herellea vaginicola) isolated between 1971 and 1979. Resistance to kanamycin, neomycin, and lividomycin was explained by an aminoglycoside-3′-phosphotransferase enzyme. The resistance of gentamicin was due to an aminoglycoside 3N-acetyltransferase type I enzyme which had not previously been described in this species. Several strains producing both enzymes showed resistance to kanamycin, gentamicin, lividomycin, neomycin, and sisomicin and susceptibility to tobramycin and amikacin.
Similar content being viewed by others
Literature Cited
Bergogne-Bérézin, E., Berthelot, G., Joly, M. L., 1978. Etude comparative de l'activité antibactérienne de 7 aminoglycosides sur 215 souches hospitaliéres d'Acinetobacter. Médecine et Maladies Infectieuses6:279–286.
Bergogne-Bérézin, E., Joly-Guillou, M. L., Moreau, N., Le Goffic, F. 1979. Présence d'enzymes de résistance chez des souches hospitaliéres d'Acinetobacter. Nouvelle Presse Médicale8:4047.
Bergogne-Bérézin, E., Zechovsky, N., Piechaud, M., Vieu, J. F., Bordini, A. 1971. Sensibilité aux antibiotiques de 240 souches de Moraxella (Acinetobacter) isolées d'infections hospitaliéres. Evolution sur 3 ans. Pathologie et Biologie19:21–22.
Bergogne-Bérézin, E., Piechaud, M., Vieu, J. F., Zechovsky, N., Bordini, A. 1970. L'infection hospitaliére àMoraxella. Annales de Médecine Interne121:1009–1026.
Biddlecome, S., Haas, M., Davies, J., Miller, G. H., Rane, D. F., Daniels, P. J. L. 1976. Enzymatic modification of aminoglycoside antibiotics: A new 3-N-acetylating enzyme fromPseudomonas aeruginosa isolate. Antimicrobial Agents and Chemotherapy9:951–955.
Brzezinska, M., Benveniste, R., Davies, J., Daniels, P. J. L., Weinstein, J. 1972. Gentamicin resistance in strains ofPseudomonas aeruginosa mediated by enzymatic N-acetylation of the deoxystreptamine moiety. Biochemistry11:761–766.
Davies, J., O'Connor, S. 1978. Enzymatic modification of aminoglycoside antibiotics: 3-N-acetyltransferase with broad specificity that determines resistance to the novel aminoglycoside apramycin. Antimicrobial Agents and Chemotherapy14:69–72.
Davies, J., Smith, D. I. 1978. Plasmid determined resistance to antimicrobial agents. Annual Review of Microbiology32:469–518.
Dowding, J. E. 1979. Novel aminoglycoside modifying enzyme from a clinical isolate ofAcinetobacter. Journal of General Microbiology110:239–241.
Glew, R. H., Moellering, R. C., Kunz, L. J. 1977. Infections withAcinetobacter calcoaceticus (Herellea vaginicola): Clinical and laboratory studies. Medicine56:79–87.
Haas, M. J., Dowding, J. E. 1975. Aminoglycoside modifying enzymes. Methods in Enzymology43:611–628.
Le Goffic, F., Martel, A. 1974. La résistance aux aminosides provoquée par une iso-enzyme: la kanamycine acétyl-transférase. Biochimie56:893–897.
Le Goffic, F., Martel, A. 1974. Méthode d'étude des enzymes inactivant les antibiotiques. Etude de la résistance de Moraxella à la Tobramycine, la kanamycine et au BBK 8. Nouvelle Presse Médicale3, suppl. no. 17:55–56.
Le Goffic, F., Moreau, N., Siegrist, S., Goldstein, F. W., Acar, J. C. 1977. La résistance plasmidique deHaemophilus sp. aux antibiotique aminoglycosidiques: isolement et étude d'une nouvelle phosphotransférase. Annales de Microbiologie128A:383–391.
Le Goffic, F., Martel, A., Moreau, N., Capmau, M. L., Soussy, C. J., Duval, J. 1977. 2″-O-phosphorylation of gentamicin components by aStaphylococcus aureus strain carrying a plasmid. Antimicrobial Agents and Chemotherapy12:26–30.
Morohoshi, T., Saito, T. 1977. Beta-lactamase and beta-lactam antibiotic resistance inAcinetobacter anitratus (syn.A. calcoaceticus). Journal of Antibiotics30:969–973.
Murray, B. E., Moellering, R. C., Jr. 1979. Aminoglycoside-modifying enzymes among clinical isolates ofAcinetobacter calcoaceticus subsp.anitratus (Herellea vaginicola): Explanation for high-level aminoglycoside resistance. Antimicrobial Agents and Chemotherapy15:190–199.
Murray, B. E., Moellering, R. C., Jr. 1980. Evidence of plasmid-mediated production of aminoglycoside modifying enzymes not previously described inAcinetobacter. Antimicrobial Agents and Chemotherapy17:30–36.
Retailliau, H. F., Hightower, A. W., Dixon, R. E., Allen, J. R. 1979.Acinetobacter calcoaceticus: A nosocomial pathogen with an unusual seasonal pattern. Journal of Infectious Diseases139:371–375.
Umezawa, Y., Yagisawa, M., Sana, T., Takeuchi, T., Umezawa, H., Matsumoto, H., Tazaki, T. 1975. Aminoglycosides 3′-phosphotransferase III, new phosphotransferase resistance mechanism. Journal of Antibiotics28:845–852.
Umezawa, Y., Yagizawa, M., Matsuhashi, Y., Magnanawa, H., Yamamoto, H., Kondo, S., Takeuchi, T., Chabbert, Y. 1973. Gentamicin acetyl transferase inEscherichia coli carrying R-factor. Journal of Antibiotics26:612–614.
Vieu, J. F., Minck, R., Bergogne-Bérézin, E. 1979. Bactériophages et lysotypie de “Acinetobacter”. Annales de Microbiologie130A:405–406.
Yagisawa, M., Yamamoto, H., Naganawa, H., Kondo, S., Takeuchi, T., Umezawa, H. 1972. A new enzyme inEscherichia coli carrying R-factor phosphorylating 3′-hydroxyl of butirosin A, kanamycin, neamine and ribostamycin. Journal of Antibiotics25:748–750.
Yamaguchi, M., Koshi, T., Kobayashi, F., Mitsuhashi, S. 1972. Phosphorylation of lividomycin byEscherichia coli carrying an R factor. Antimicrobial Agents and Chemotherapy2:142–146.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bergogne-Berézin, E., Joly, M.L., Moreau, N. et al. Aminoglycoside-modifying enzymes in clinical isolates ofAcinetobacter calcoaceticus . Current Microbiology 4, 361–364 (1980). https://doi.org/10.1007/BF02605378
Issue Date:
DOI: https://doi.org/10.1007/BF02605378